Hear Dr. Dennis Bashaw, Former Director, Division of Clinical Pharmacology-3, FDA, give his expert opinion on the FDA’s Predictive Toxicology Roadmap.
Published in December 2017, the Roadmap provides a six-point outline for predictive toxicology. It is designed to spur joint action between the FDA, industry, and academicians to develop better tools and encourage their use.
You'll learn about:
- Current trends in toxicity and safety evaluation
- State-of-the-art methods to predict toxicity risk
- Case studies illustrating the need for better screening of compounds prior to initiating clinical studies
Fill out the form to download the webinar recording and slides.